Open access · US-GOV via ClinicalTrials.gov Clinical trial

Clinical Study on 28 Day Continuous Improvement of Post-rejuvenation-treatment Skin With Formulations of A Proprietary Anti-aging Complex Composition

Authors not listed

Botanee Group Co., Ltd. · 2023

Mitochondrial dysfunction Human Randomized controlled trial

Abstract

This clinical trial aims to learn about the efficacy of MLYAAT-1002® (a proprietary anti-aging complex, MLYAAT is short for "multi-layer anti-ageing technology" ) in female subjects who have newly received the rejuvenation treatment by comparing visual clinical scores, skin attributes measurement and image analysis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-31 MST

Cite this

APA

Anonymous. (2023). Clinical Study on 28 Day Continuous Improvement of Post-rejuvenation-treatment Skin With Formulations of A Proprietary Anti-aging Complex Composition. <em>Botanee Group Co., Ltd.</em>. https://clinicaltrials.gov/study/NCT06140628

Vancouver

Anonymous. Clinical Study on 28 Day Continuous Improvement of Post-rejuvenation-treatment Skin With Formulations of A Proprietary Anti-aging Complex Composition. Botanee Group Co., Ltd.. 2023.

BibTeX

@misc{anon2023Clinic, title = {Clinical Study on 28 Day Continuous Improvement of Post-rejuvenation-treatment Skin With Formulations of A Proprietary Anti-aging Complex Composition}, author = {Anonymous}, journal = {Botanee Group Co., Ltd.}, year = {2023}, }